Skip to main content

Market Overview

Why Amgen's Stock Is Trading Higher Today

Why Amgen's Stock Is Trading Higher Today

Amgen, Inc. (NASDAQ: AMGN) shares are trading higher on Monday after receiving an upgrade.

Raymond James analyst Dane Leone upgraded the stock from Market Perform to Outperform and announced a $255 price target.

See Also: The Week Ahead In Biotech -- Clinical Readouts, COVID-19 News Flow In Focus Amid Continuing Uncertainty

Amgen is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California.

Amgen's shares were trading up 4% to $206.34 at time of publication. The stock has a 52-week high of $244.99 and a 52-week low of $166.30.

Latest Ratings for AMGN

Sep 2021Daiwa CapitalDowngradesOutperformNeutral
Sep 2021Morgan StanleyDowngradesOverweightEqual-Weight
Aug 2021SVB LeerinkMaintainsMarket Perform

View More Analyst Ratings for AMGN
View the Latest Analyst Ratings


Related Articles (AMGN)

View Comments and Join the Discussion!

Posted-In: why it's movingNews Upgrades Price Target Analyst Ratings Movers Trading Ideas

Latest Ratings

RYCEYRedburn PartnersUpgrades
MMENCanaccord GenuityUpgrades0.400
VTEXMorgan StanleyUpgrades30.0
CRMRBC CapitalMaintains325.0
NKEB of A SecuritiesMaintains160.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at